NYSE
ADCT
ADC Therapeutics SA
- Health Care
- Switzerland
- Listed 2020
- 1 day
- +5.6%
- 1 month
- −16.3%
- 1 year
- −57.2%
$1.13 · Mkt cap $144M
At the 6 Aug 2026 close
NYSE
ADC Therapeutics SA
$1.13 · Mkt cap $144M
At the 6 Aug 2026 close
ADC Therapeutics SA trades under the ticker ADCT on NYSE, in the Health Care sector (Biotechnology: Pharmaceutical Preparations). It has been listed since 2020. Its market capitalisation is $144M. The last closing price was $1.13, on 6 Aug 2026. No price-to-earnings ratio is shown, because it did not report positive earnings in its last annual filing. Over the past year the share price is −57.2%, and −16.3% over the past month. Returns are price returns and exclude dividends.
This page exists because ADCT is one of the shares What A Share can show you. It is not a recommendation, and its appearance here says nothing about whether the company is worth owning.